ATE480232T1 - Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden - Google Patents
Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werdenInfo
- Publication number
- ATE480232T1 ATE480232T1 AT03732288T AT03732288T ATE480232T1 AT E480232 T1 ATE480232 T1 AT E480232T1 AT 03732288 T AT03732288 T AT 03732288T AT 03732288 T AT03732288 T AT 03732288T AT E480232 T1 ATE480232 T1 AT E480232T1
- Authority
- AT
- Austria
- Prior art keywords
- helicobacter pylori
- pleuromutilines
- diseases caused
- treat diseases
- pleuromutilin
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- ZRZNJUXESFHSIO-UHFFFAOYSA-N Pleuromutilin Natural products CC1C(O)C(C)(C=C)CC(OC(=O)CO)C2(C)C(C)CCC31C2C(=O)CC3 ZRZNJUXESFHSIO-UHFFFAOYSA-N 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical compound C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0209262.5A GB0209262D0 (en) | 2002-04-23 | 2002-04-23 | Organic compounds |
| PCT/EP2003/004173 WO2003090740A1 (en) | 2002-04-23 | 2003-04-22 | Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE480232T1 true ATE480232T1 (de) | 2010-09-15 |
Family
ID=9935350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03732288T ATE480232T1 (de) | 2002-04-23 | 2003-04-22 | Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7790749B2 (de) |
| EP (1) | EP1501495B1 (de) |
| JP (1) | JP2005529131A (de) |
| AT (1) | ATE480232T1 (de) |
| AU (1) | AU2003239813A1 (de) |
| DE (1) | DE60334094D1 (de) |
| ES (1) | ES2354972T3 (de) |
| GB (1) | GB0209262D0 (de) |
| SI (1) | SI1501495T1 (de) |
| TW (1) | TW200306294A (de) |
| WO (1) | WO2003090740A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| WO2007000004A1 (en) * | 2005-06-27 | 2007-01-04 | Nabriva Therapeutics Forschungs Gmbh | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
| GB0515995D0 (en) * | 2005-08-03 | 2005-09-07 | Sandoz Ag | Organic compounds |
| EP1808431A1 (de) * | 2006-01-16 | 2007-07-18 | Nabriva Therapeutics Forschungs GmbH | Mutilin Derivate und ihre Verwendung als Arzneimittel |
| EP1972618A1 (de) | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben |
| EP2014645A1 (de) * | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Pleuromutilin-derivate und ihre Verwendung als antimikrobielles Wirkungsmittel |
| EP2159220A1 (de) | 2008-09-02 | 2010-03-03 | Nabriva Therapeutics AG | Organische Verbindungen |
| CN102924350B (zh) * | 2012-10-31 | 2014-04-09 | 中国农业科学院兰州畜牧与兽药研究所 | 截短侧耳素衍生物及其制备方法和应用 |
| CN103265442B (zh) * | 2013-06-05 | 2017-02-08 | 北京理工大学 | 一类新型截短侧耳素衍生物及其制备方法和抗肿瘤用途 |
| HRP20210010T1 (hr) | 2015-06-17 | 2021-03-05 | Nabriva Therapeutics GmbH | Injekcijske farmaceutske formulacije lefamulina |
| TWI762573B (zh) | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
| CN116687904B (zh) * | 2023-03-28 | 2025-05-06 | 中国药科大学 | 截短侧耳素抗生素在制备抗肿瘤及逆转分子靶向治疗耐药的药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3560511D1 (en) | 1984-02-17 | 1987-10-01 | Sandoz Ag | Pleuromutilin derivatives, process for their preparation and their use |
| CA2042138A1 (en) | 1990-04-18 | 1992-11-09 | Hiroo Abe | Agents for preventing or treating bacterial diseases of fishes |
| AUPO758297A0 (en) | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
| GB9918037D0 (en) * | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
| WO2001074788A1 (en) * | 2000-04-04 | 2001-10-11 | Smithkline Beecham Plc | 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| DE10030781A1 (de) | 2000-06-29 | 2002-01-17 | Hassan Jomaa | Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen |
| GB0017031D0 (en) * | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
| PE20020676A1 (es) | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
| GB0024811D0 (en) * | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
-
2002
- 2002-04-23 GB GBGB0209262.5A patent/GB0209262D0/en not_active Ceased
-
2003
- 2003-04-21 TW TW092109216A patent/TW200306294A/zh unknown
- 2003-04-22 WO PCT/EP2003/004173 patent/WO2003090740A1/en not_active Ceased
- 2003-04-22 JP JP2003587374A patent/JP2005529131A/ja active Pending
- 2003-04-22 DE DE60334094T patent/DE60334094D1/de not_active Expired - Lifetime
- 2003-04-22 AU AU2003239813A patent/AU2003239813A1/en not_active Abandoned
- 2003-04-22 EP EP03732288A patent/EP1501495B1/de not_active Expired - Lifetime
- 2003-04-22 AT AT03732288T patent/ATE480232T1/de not_active IP Right Cessation
- 2003-04-22 SI SI200331922T patent/SI1501495T1/sl unknown
- 2003-04-22 US US10/510,532 patent/US7790749B2/en not_active Expired - Lifetime
- 2003-04-22 ES ES03732288T patent/ES2354972T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003239813A1 (en) | 2003-11-10 |
| HK1073250A1 (en) | 2005-09-30 |
| JP2005529131A (ja) | 2005-09-29 |
| US7790749B2 (en) | 2010-09-07 |
| WO2003090740A1 (en) | 2003-11-06 |
| GB0209262D0 (en) | 2002-06-05 |
| EP1501495A1 (de) | 2005-02-02 |
| SI1501495T1 (sl) | 2011-01-31 |
| US20050131023A1 (en) | 2005-06-16 |
| EP1501495B1 (de) | 2010-09-08 |
| DE60334094D1 (de) | 2010-10-21 |
| TW200306294A (en) | 2003-11-16 |
| ES2354972T3 (es) | 2011-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| DE60215787D1 (de) | Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern | |
| CY1107484T1 (el) | Παραγωγα γκελνταναμυκινης χρησιμοποιουμενα για τη θεραπεια καρκινου | |
| MY169308A (en) | Treatment of tnf? related disorders | |
| DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| ATE480232T1 (de) | Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden | |
| ZA200407216B (en) | Tuberculosis treatment. | |
| NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
| DE602004022285D1 (de) | Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika | |
| ATE411016T1 (de) | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| ATE404202T1 (de) | Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| DE602004011051D1 (de) | Verfahren zur behandlung von krankheiten mit hsp90-hemmenden mitteln in kombination mit antimetaboliten | |
| DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| PL371205A1 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
| DE60305068D1 (de) | Behandlung von mastalgie mit4-hydroxy-tamoxifen | |
| DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE406171T1 (de) | Aplidine zur behandlung von multiplem myelom | |
| ATE304861T1 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| ATE486612T1 (de) | Verfahren zur behandlung von diabetes typ 2 | |
| ATE392212T1 (de) | Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen | |
| DE60224064D1 (de) | Fragmente des humanen zn-alpha2-glykoproteins und deren verwendung in methoden zur behandlung der fettleibigkeit | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |